{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:35:22Z","timestamp":1775979322815,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.thromres.2004.09.001","type":"journal-article","created":{"date-parts":[[2004,10,13]],"date-time":"2004-10-13T17:53:40Z","timestamp":1097690020000},"page":"219-228","source":"Crossref","is-referenced-by-count":30,"title":["In vitro effect of cyclosporin A, mitomycin C and prednisolone on cell kinetics in cultured human umbilical vein endothelial cells"],"prefix":"10.1016","volume":"115","author":[{"given":"Yoshinobu","family":"Seki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Toba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Fuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroe","family":"Niwano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoyu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifusa","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2004.09.001_bib1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","article-title":"Cyclosporine","volume":"321","author":"Kahan","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2004.09.001_bib2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/00007890-199511000-00012","article-title":"Microangiopathy following allogenic marrow transplantation","volume":"60","author":"Kalhs","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.thromres.2004.09.001_bib3","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.V73.7.2018.2018","article-title":"Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation","volume":"73","author":"Holler","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.09.001_bib4","first-page":"247","article-title":"Bone marrow transplant-associated thrombotic microangiopathy: a case series","volume":"15","author":"Zeigler","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.thromres.2004.09.001_bib5","first-page":"495","article-title":"Thrombotic microangiopathy following bone marrow transplantation","volume":"14","author":"Pettitt","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.thromres.2004.09.001_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00007890-199401000-00016","article-title":"Pulmonary hemorrhage as a cause of death in allogenic bone marrow recipients with severe acute graft-versus-host disease","volume":"57","author":"Wojno","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.thromres.2004.09.001_bib7","first-page":"1006","article-title":"Diffuse alveolar hemorrhage in allogenic bone marrow transplantation. A postmortem study","volume":"151","author":"Agusti","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.thromres.2004.09.001_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0305-7372(76)80019-9","article-title":"Mitomycin C: a review","volume":"3","author":"Crooke","year":"1976","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.thromres.2004.09.001_bib9","first-page":"946","article-title":"Crosslinking of DNA by enzymatically or chemically activated mitomycins and porfiromycins, bifunctionally \u201calkylating\u201d antibiotics","volume":"23","author":"Szybalski","year":"1964","journal-title":"Fed. Proc."},{"key":"10.1016\/j.thromres.2004.09.001_bib10","first-page":"117","article-title":"Isolation of Chinese hamster ovary cell mutants deficient in excision repair and mitomycin C bioactivation","volume":"49","author":"Dulhanty","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.thromres.2004.09.001_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00005792-197909000-00004","article-title":"Microangiopathic hemolytic anemia and cancer: a review","volume":"58","author":"Antman","year":"1979","journal-title":"Medicine"},{"key":"10.1016\/j.thromres.2004.09.001_bib12","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/1097-0142(19861001)58:7<1428::AID-CNCR2820580709>3.0.CO;2-J","article-title":"A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma","volume":"58","author":"Sheldon","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.thromres.2004.09.001_bib13","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/1097-0142(19800501)45:9<2252::AID-CNCR2820450906>3.0.CO;2-N","article-title":"Microangiopathic hemolytic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil","volume":"45","author":"Gulati","year":"1980","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.thromres.2004.09.001_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bmt.1702546","article-title":"Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy","volume":"26","author":"Lewis","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.thromres.2004.09.001_bib15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood.V89.4.1224","article-title":"Thrombotic thrombocytopenic purpura (TTP) and adult\/sporadic hemolytic\u2013uremic syndrome (HUS) plasma induce apoptosis in restricted lineage of human microvascular endothelial cells","volume":"89","author":"Mitra","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.09.001_bib16","first-page":"499","article-title":"von Willebrand factor as a marker of endothelial cell activation following BMT","volume":"10","author":"Collins","year":"1992","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.thromres.2004.09.001_bib17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/00007890-199311000-00032","article-title":"Cyclosporine and cremaphor modulate von Willebrand factor release from cultured human endothelial cells","volume":"56","author":"Collins","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.thromres.2004.09.001_bib18","first-page":"955","article-title":"Vascular endothelial lesion in patients undergoing bone marrow transplantation","volume":"18","author":"Richard","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.thromres.2004.09.001_bib19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bmt.1701180","article-title":"The levels of soluble P-selectin, von Willebrand factor and thrombomodulin in patients with neurological complications after allogeneic bone marrow transplantation","volume":"21","author":"Takatsuka","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.thromres.2004.09.001_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-1759(95)00050-K","article-title":"Simultaneous three-color analysis of the surface phenotype and DNA\u2013RNA quantitation using 7-amino-actinomysin D and pyronin Y","volume":"182","author":"Toba","year":"1995","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.thromres.2004.09.001_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/cyto.990130110","article-title":"Improved staining method for the simultaneous flow cytofluorometric analysis of DNA content, S-phase fraction, and surface phenotype using single laser instrumentation","volume":"13","author":"Toba","year":"1992","journal-title":"Cytometry"},{"key":"10.1016\/j.thromres.2004.09.001_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2004.09.001_bib23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1172\/JCI111587","article-title":"Platelet membrane glycoprotein IIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenia","volume":"74","author":"Beardsley","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2004.09.001_bib24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/cvr\/28.3.400","article-title":"Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine\u2013xanthine oxidase and neutrophils","volume":"28","author":"Yue","year":"1994","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2004.09.001_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0038-1645037","article-title":"Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies","volume":"63","author":"Ishii","year":"1990","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.09.001_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00690212","article-title":"Genetic instability as a consequence of inappropriate entry into and progression through S-phase","volume":"14","author":"Almasan","year":"1995","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.thromres.2004.09.001_bib27","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1038\/sj.onc.1202923","article-title":"Control of E2F activity by p21 Waf1\/Cip1","volume":"18","author":"Delavaine","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.thromres.2004.09.001_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0923-1811(95)00480-7","article-title":"FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0\/G1 phase of the cell cycle","volume":"12","author":"Karashima","year":"1996","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.thromres.2004.09.001_bib29","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1073\/pnas.80.18.5573","article-title":"Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine","volume":"80","author":"Dolbeare","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2004.09.001_bib30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1177\/33.8.3860561","article-title":"Detection of 5-Bromodeoxyuridine (BrdUrd) incorporation by monoclonal antibodies: role of the DNA denaturation step","volume":"33","author":"Moran","year":"1985","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.thromres.2004.09.001_bib31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cyto.990080405","article-title":"An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry","volume":"8","author":"Schutte","year":"1987","journal-title":"Cytometry"},{"key":"10.1016\/j.thromres.2004.09.001_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.cb.10.110194.000245","article-title":"The retinoblastoma protein: more than a tumor suppressor","volume":"10","author":"Riley","year":"1994","journal-title":"Cell Biol."},{"key":"10.1016\/j.thromres.2004.09.001_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0955-0674(93)90102-V","article-title":"Integration of cell cycle control with transcriptional regulation by the retinoblastoma protein","volume":"5","author":"Hollingsworth","year":"1993","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.thromres.2004.09.001_bib34","first-page":"1","article-title":"Significance of the retinoblastoma gene in human cancer","volume":"6","author":"Cordon-Cardo","year":"1992","journal-title":"Princ. Pract. Oncol."},{"key":"10.1016\/j.thromres.2004.09.001_bib35","first-page":"153","article-title":"Functional analysis of the retinoblastoma gene product and of Rb-SV40T antigen complexes","volume":"12","author":"Livingston","year":"1992","journal-title":"Cancer Surv."},{"key":"10.1016\/j.thromres.2004.09.001_bib36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1055\/s-2007-1003522","article-title":"Thrombomodulin","volume":"13","author":"Esmon","year":"1987","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2004.09.001_bib37","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/S0021-9258(17)35728-9","article-title":"The effect of bovine thrombomodulin on the specificity of bovine thrombin","volume":"261","author":"Jakubowski","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2004.09.001_bib38","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1016\/S0021-9258(18)83649-3","article-title":"The roles of protein C and thrombomodulin in the regulation of blood coagulation","volume":"264","author":"Esmon","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2004.09.001_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/blood.V75.2.329.329","article-title":"Structure and function of thrombomodulin: a natural anticoagulant","volume":"75","author":"Dittman","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.09.001_bib40","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/j.1460-2075.1987.tb02448.x","article-title":"Structure and expression of human thrombomodulin, a thrombin receptor on endothelium actina as a cofactor for protein C activation","volume":"6","author":"Suzuki","year":"1987","journal-title":"EMBO J."},{"key":"10.1016\/j.thromres.2004.09.001_bib41","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1055\/s-0038-1648199","article-title":"Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells","volume":"65","author":"Ishii","year":"1991","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.09.001_bib42","first-page":"455","article-title":"Cyclosporin-induced endothelial cell injury","volume":"55","author":"Zoja","year":"1986","journal-title":"Lab. Invest."},{"key":"10.1016\/j.thromres.2004.09.001_bib43","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00007890-199211000-00002","article-title":"The acute effect of FK506 and cyclosporine of endothelial cell function and renal vascular resistance","volume":"54","author":"Benigni","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.thromres.2004.09.001_bib44","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0041-1345(98)00338-8","article-title":"Cyclosporin A-associated thrombotic thrombocytopenic purpura following lung transplantation","volume":"30","author":"Roberts","year":"1988","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.thromres.2004.09.001_bib45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bmt.1701359","article-title":"Thrombotic microangiopathy following allogenic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis","volume":"22","author":"Paquette","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.thromres.2004.09.001_bib46","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1365-2141.1998.00602.x","article-title":"Successful use of cyclosporine A in the treatment of refractory thrombocytopenic purpura","volume":"100","author":"Hand","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2004.09.001_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<57::AID-AJH10>3.0.CO;2-6","article-title":"Chronic relapsing thrombocytopenic purpura: role of therapy with cyclosporine","volume":"57","author":"Pasquale","year":"1998","journal-title":"Am. J. Hematol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804004736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804004736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T14:35:32Z","timestamp":1624718132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384804004736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0049384804004736"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2004.09.001","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}